Description
Jakavi 15mg is a prescription medication containing the active ingredient ruxolitinib. It is a targeted kinase inhibitor primarily used to treat adults with bone marrow disorders like myelofibrosis, polycythemia vera, and certain types of graft-versus-host disease (GvHD) by blocking enzymes that trigger abnormal cell growth. [1, 2, 3, 4]
Key Details and Uses
- Active Ingredient: Ruxolitinib (as phosphate). [1]
- Primary Indications:
- Myelofibrosis: Treats an enlarged spleen or symptoms in intermediate or high-risk cases.
- Polycythemia Vera: Used for patients who are resistant to or cannot tolerate hydroxyurea.
- Graft-versus-Host Disease (GvHD): Prescribed for adults and children 12 and older suffering from acute or chronic GvHD who have not responded well to steroids or other systemic treatments
Reviews
There are no reviews yet.